10,182 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by StoneX Group Inc.

StoneX Group Inc. bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 10,182 shares of the company’s stock, valued at approximately $544,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of DOCS. Global Retirement Partners LLC lifted its holdings in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. lifted its stake in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares during the last quarter. Larson Financial Group LLC boosted its holdings in shares of Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after purchasing an additional 250 shares in the last quarter. Optimum Investment Advisors bought a new position in shares of Doximity during the 4th quarter valued at about $43,000. Finally, Morse Asset Management Inc purchased a new position in shares of Doximity during the 3rd quarter valued at about $46,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Insiders Place Their Bets

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 37.40% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on DOCS shares. Needham & Company LLC increased their price target on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Leerink Partners upgraded shares of Doximity from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Mizuho upped their price target on shares of Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Wells Fargo & Company reiterated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Finally, The Goldman Sachs Group increased their target price on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $64.22.

Doximity Price Performance

Shares of NASDAQ DOCS opened at $57.96 on Thursday. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The stock has a market capitalization of $10.82 billion, a P/E ratio of 57.96, a P/E/G ratio of 4.10 and a beta of 1.34. The company’s 50-day moving average is $65.63 and its 200 day moving average is $54.84.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.